Nu Image Medical prices sermorelin at the same figure whether it is bought as an injection, a tablet or a nasal spray. Two other compounds it lists say coming soon where their price would be, while showing figures that belong to other products entirely.
What Nu Image Medical charges
Sermorelin: $169/mo — "As low as", per month, and the identical figure on all three formats the seller lists — injection, rapid-dissolve tablet and nasal spray; the same page adds "*Subject to medical consultation / If prescribed. Compounded medications are not approved by the FDA" and marks each card "Compounded Medication / Rx Only"
Nu Image Medical is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
One figure across three formats
The sermorelin listing appears three times, once per delivery format, and all three carry the same figure with the same wording. Choosing between an injection, a rapid-dissolve tablet and a nasal spray does not change the published price here.
That is unusual. On most sellers compared here the format changes the number, and the cheapest published figure often belongs to the format a reader was not shopping for.
The page qualifies the figure twice over, saying it is subject to a consultation and applies if prescribed, and marking each card as a compounded medication available on prescription only. It also states on the page that compounded medications are not approved by the federal regulator.
Eight of the fifty-three sellers here sell exactly one compound this site tracks, and this is one of them. The rest of the catalogue is weight loss, sexual health and hormone products.
A price on the page that is not this product's price
Two more compounds compared on this site have their own pages here, and both print coming soon where a figure would be. Neither is purchasable and neither is declared as sold on this row.
Both of those pages nonetheless render dollar figures in full view. They sit under a heading inviting a reader to explore more treatment options, and they belong to a vitamin injection, a sublingual weight product and a topical gel.
A reader scanning either page for a number will find one, and it will be the wrong one. This site takes a price from the card that carries the product name, never from the page the card happens to sit on.
That is why this row declares one compound rather than three. Declaring the other two would put this seller on two boards it does not yet sell into, and no figure exists for either that belongs to it.
A venue, no governing law, and twenty-one screens of terms
The terms name the operating company and a street address, and they name an exclusive venue in one county for any claim. They do not name a governing law at all.
The county named is not the county the company's own published address sits in, and this site records the venue rather than promoting it into a governing-law state.
The terms page is paginated across twenty-one screens and only the first one renders. The arbitration and venue wording exists in the page's markup and does not appear on screen, and no control to advance the page could be found.
So a reader who opens the terms and reads what is in front of them will find no venue clause and no arbitration clause at all.
Available in most states, and no list of them
The site's own header says it has been operating since 2008 and that it is available in most states. The terms say the services may not be available in a reader's state.
Neither sentence is a list, and no list appears anywhere else. Twenty-nine of the fifty-three sellers here publish none, and this is one of them.
Eleven of the fifty-three sellers here name the facility that fills an order; this is one of the forty-two that do not, and nothing on the page describes lab work as included.
The compound compared here is not an approved finished drug in the form sold, which the seller's own page says plainly rather than leaving to a footer.
Who it's for
Readers who want one sermorelin figure that holds across three delivery formats.
Buyers who want the seller to say on the product page that a compounded preparation is not an approved drug.
Shoppers comparing an injection against an oral or nasal route without a price penalty for choosing one.
Anyone who wants a long-established brand with a named company behind it.
Who should look elsewhere
Buyers looking for NAD+ or PT-141 here, because both say coming soon and neither is priced.
Readers who need a governing law named, since the terms name only a venue.
Anyone who needs to know before an intake whether their state is served.
Shoppers who want the compounding pharmacy named or lab work included.
Readers who want more than one compound compared here from a single seller.
Strengths
Prints the same figure across the injection, the tablet and the nasal spray, so choosing a format does not change the published price
Marks every card as a compounded medication and states on the page that compounded medications are not FDA-approved
Names its operating company and a street address in its terms and footer
Says outright that products not yet available are coming soon rather than quietly listing them as purchasable
Trade-offs
Its NAD+ and PT-141 pages render dollar figures that belong to a cross-sell strip for unrelated products, beside a "Coming soon" where those products' own prices would be
No governing-law clause exists in its terms — only a venue in one Florida county, which is not the county its own address is in
The terms page is paginated across twenty-one screens and only the first renders, so the venue and arbitration wording is invisible to a normal read
Publishes no state list, only the phrase available in most states
No compounding pharmacy is named and no lab work is described as included
How we verified this
Read the sermorelin page and the peptide catalogue as rendered text in a browser and took each figure from the card carrying the product name.
Opened the pages for the two compounds marked coming soon, confirmed that each prints no figure of its own, and traced the visible figures on those pages to the cross-sell strip and the products they belong to.
Declined to record either of those figures anywhere, and declined to declare either compound as sold, because a product marked coming soon with no figure is not a product on sale.
Read the terms for an operating company, an address, a governing law and a venue, and recorded that no governing law appears while a venue does.
Noted that the terms page is paginated and that only its first screen renders, so the venue and arbitration wording is in the markup and not on screen.
Censused the header, the catalogue and the terms for a state list and found only the phrase available in most states and a sentence saying the service may not be available in a reader's state.
Confirmed the host answers a nonsense path with its own not-found page at two path depths in the same pass.
Searched the published federal warning-letter record for the company name; the search returned a block of unrelated companies matched on body text and every returned row was read, with no letter to this company among them. That record does not include untitled letters.
Re-counted the one-compound, no-state-list and pharmacy-naming claims against the current roster rather than reusing earlier figures.
A provider to compare Nu Image Medical against
Auren Rx
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.
No. The injection, the rapid-dissolve tablet and the nasal spray all carry the same published figure with the same wording.
What do the prices on the NAD+ and PT-141 pages mean?
They belong to other products. Both of those pages print coming soon where their own price would be, and the visible figures sit under a heading inviting a reader to explore other treatments — a vitamin injection, a sublingual weight product and a topical gel.
Can I buy NAD+ or PT-141 here?
Not according to the seller's own pages, which mark both coming soon and publish no price for either. Neither is recorded as sold on this row.
Which state's law governs a dispute?
The terms do not say. They name an exclusive venue in one county and no governing law, and the county named is not the one the company's published address sits in.
Which states are served?
The site does not publish a list. Its header says available in most states and its terms say the services may not be available in a reader's state.
Nu Image Medical is not a paid partner; this link may earn a commission if that changes. Full disclosure.